Literature DB >> 15530427

Gender difference in serum bisphenol A levels may be caused by liver UDP-glucuronosyltransferase activity in rats.

Toru Takeuchi1, Osamu Tsutsumi, Naohito Nakamura, Yumiko Ikezuki, Yasushi Takai, Tetsu Yano, Yuji Taketani.   

Abstract

Gender difference in human bisphenol A (BPA) concentrations was revealed by determining serum BPA. We studied the serum concentrations and the metabolism of BPA in rats by an HPLC system. Rat serum BPA concentrations were significantly higher in males (24.9+/-7.38 ng/ml, P=0.026, n=10) than in females (8.27+/-3.11 ng/ml, n=10), as in humans. The resultant enzyme reaction products of BPA glucuronidation in the rat liver microsomes fraction were analyzed by an HPLC system. The ratio of BPA glucuronidation in the microsome reaction was significantly higher (P=0.015) in female than in male rats. The mRNA expression of UDP-glucuronosyltransferase 2B1 (UGT2B1), an isoform of UGT related to BPA glucuronidation, in the rat liver was analyzed by a real-time quantitative RT-PCR. The relative expression level of UGT2B1 mRNA was significantly higher (P<0.001) in female than in male rat livers. The gender difference in serum BPA concentrations may be explained by the difference in clearance based on the UGT activities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530427     DOI: 10.1016/j.bbrc.2004.10.073

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Bisphenol A, 4-tert-octylphenol, and 4-nonylphenol in the Gulf of Gdańsk (Southern Baltic).

Authors:  Marta Staniszewska; Lucyna Falkowska; Paweł Grabowski; Justyna Kwaśniak; Stella Mudrak-Cegiołka; Andrzej R Reindl; Adam Sokołowski; Emilia Szumiło; Aleksandra Zgrundo
Journal:  Arch Environ Contam Toxicol       Date:  2014-04-22       Impact factor: 2.804

2.  Developmental bisphenol A (BPA) exposure leads to sex-specific modification of hepatic gene expression and epigenome at birth that may exacerbate high-fat diet-induced hepatic steatosis.

Authors:  Rita S Strakovsky; Huan Wang; Nicki J Engeseth; Jodi A Flaws; William G Helferich; Yuan-Xiang Pan; Stéphane Lezmi
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-05       Impact factor: 4.219

3.  Urinary bisphenol A and obesity in adults: results from the Canadian Health Measures Survey.

Authors:  Minh T Do; Vicky C Chang; Michelle A Mendez; Margaret de Groh
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-12       Impact factor: 3.240

Review 4.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

Review 5.  Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role?

Authors:  Emily S Barrett; Marissa Sobolewski
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

6.  Species and gender differences affect the metabolism of emodin via glucuronidation.

Authors:  Wei Liu; Lan Tang; Ling Ye; Zheng Cai; Bijun Xia; Jiajie Zhang; Ming Hu; Zhongqiu Liu
Journal:  AAPS J       Date:  2010-05-14       Impact factor: 4.009

7.  Association between bisphenol A and abnormal free thyroxine level in men.

Authors:  Chutintorn Sriphrapradang; La-or Chailurkit; Wichai Aekplakorn; Boonsong Ongphiphadhanakul
Journal:  Endocrine       Date:  2013-02-02       Impact factor: 3.633

8.  Mechanism of gender-divergent UDP-glucuronosyltransferase mRNA expression in mouse liver and kidney.

Authors:  David B Buckley; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2009-01-08       Impact factor: 3.922

Review 9.  Sex differences in the expression of hepatic drug metabolizing enzymes.

Authors:  David J Waxman; Minita G Holloway
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

10.  Does rapid metabolism ensure negligible risk from bisphenol A?

Authors:  Gary Ginsberg; Deborah C Rice
Journal:  Environ Health Perspect       Date:  2009-07-14       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.